Scott R Solomon

10PUBLICATIONS
60CO-AUTHORS
Liquid biopsiesLanguage documentation and descriptionApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 07, 2025
Lisocabtagene Maraleucel Versus Standard of Care for Second-Line Relapsed/Refractory Large B-Cell Lymphoma: 3-Year Follow-Up From the Randomized, Phase III TRANSFORM Study.

Manali Kamdar, Scott R Solomon, Jon Arnason

|Jul 31, 2024
HLA evolutionary divergence (HED) informs the effect of HLA-B mismatch on outcomes after haploidentical transplantation.

Melhem Solh, Michael T Aubrey, Xu Zhang

|Dec 10, 2023
Lisocabtagene Maraleucel in Relapsed/Refractory Mantle Cell Lymphoma: Primary Analysis of the Mantle Cell Lymphoma Cohort From TRANSCEND NHL 001, a Phase I Multicenter Seamless Design Study.

Michael Wang, Tanya Siddiqi, Leo I Gordon

|Feb 10, 2023
Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma.

Paula Rodriguez-Otero, Sikander Ailawadhi, Bertrand Arnulf

Pageof 2